Solesence (SLSN) & Its Rivals Financial Review

Solesence (NASDAQ:SLSN) is one of 55 public companies in the “Personal Care Products” industry, but how does it weigh in compared to its peers? We will compare Solesence to similar businesses based on the strength of its valuation, dividends, risk, analyst recommendations, earnings, profitability and institutional ownership.

Risk & Volatility

Solesence has a beta of 1.31, suggesting that its share price is 31% more volatile than the S&P 500. Comparatively, Solesence’s peers have a beta of 0.81, suggesting that their average share price is 19% less volatile than the S&P 500.

Institutional and Insider Ownership

70.2% of Solesence shares are held by institutional investors. Comparatively, 48.7% of shares of all “Personal Care Products” companies are held by institutional investors. 4.8% of Solesence shares are held by insiders. Comparatively, 12.2% of shares of all “Personal Care Products” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Solesence and its peers, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solesence	1	0	0	0	1.00
Solesence Competitors	830	2774	3552	210	2.43

As a group, “Personal Care Products” companies have a potential downside of 11.75%. Given Solesence’s peers stronger consensus rating and higher possible upside, analysts clearly believe Solesence has less favorable growth aspects than its peers.

Earnings & Valuation

This table compares Solesence and its peers revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Solesence	$62.06 million	$1.79 million	83.03
Solesence Competitors	$7.90 billion	$1.08 billion	6.43

Solesence’s peers have higher revenue and earnings than Solesence. Solesence is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Solesence and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Solesence	1.56%	5.39%	1.78%
Solesence Competitors	-5.79%	-111.84%	0.08%

Summary

Solesence peers beat Solesence on 7 of the 13 factors compared.

About Solesence

Nanophase Technologies Corporation provides engineered materials, formulation development, and commercial manufacturing with an integrated family of technologies in the United States. It offers surface engineered zinc oxide and titanium dioxide for sunscreens and personal care products; fully formulated cosmetics, sun care, and skin care under the Solésence brand name; and advanced materials products, such as architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and various surface finishing technologies applications. The company was incorporated in 1989 and is headquartered in Romeoville, Illinois.